原发性肺癌（以下简称「肺癌」）是中国发病率和死亡率最高的恶性肿瘤，2022 年中国肺癌新发病例约为 106.06 万，死亡病例约 73.33 万。在所有肺癌中，非小细胞肺癌（NSCLC）约占 85%。在晚期 NSCLC 及早中期 NSCLC 需要辅助治疗的患者当中，国内外指南统一推荐进行 ...

The robust and sustained clinical responses to crizotinib therapy in patients with relapsed ALCL and metastatic or unresectable IMT highlight the importance of the ALK pathway in these diseases.

A clinical pathway blends expertise from many providers. The primary goal of a clinical pathway is to produce maximum value at each practice site. Dr Konduri’s institution strongly emphasizes the ...

Setting Quality Improvement Priorities for Women Receiving Systemic Therapy for Early-Stage Breast Cancer by Using Population-Level Administrative Data The robust and sustained clinical responses to ...

AUSTIN, Texas , Oct. 24, 2024 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for ...